See more : Aoshikang Technology Co., Ltd. (002913.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Medinice S.A. (ICE.WA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medinice S.A., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Pershing Square Holdings, Ltd. (PSH.L) Income Statement Analysis – Financial Results
- Space Incubatrics Technologies (SPACEINCUBA.BO) Income Statement Analysis – Financial Results
- JD Orgochem Limited (JDORGOCHEM.BO) Income Statement Analysis – Financial Results
- Voice Assist, Inc. (VSST) Income Statement Analysis – Financial Results
- Magnate Technology Co., Ltd. (4541.TWO) Income Statement Analysis – Financial Results
Medinice S.A. (ICE.WA)
About Medinice S.A.
Medinice S.A. provides medical solution for cardiology and cardiac surgery. The company support scientists for product commercialization including prototyping, clinical trials and certification, and product sales. Medinice S.A. was founded in 2012 and is based in Warsaw, Poland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 225.00K | 246.00K | 288.00K | 372.00K | 164.39K | 1.11K | 243.04K | 184.74K |
| Cost of Revenue | 150.00K | 111.00K | 74.00K | 122.00K | 29.16K | 23.31K | 15.05K | 15.15K |
| Gross Profit | 75.00K | 135.00K | 214.00K | 250.00K | 135.23K | -22.20K | 227.99K | 169.60K |
| Gross Profit Ratio | 33.33% | 54.88% | 74.31% | 67.20% | 82.26% | -1,999.55% | 93.81% | 91.80% |
| Research & Development | 75.00K | 85.00K | 80.00K | 69.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 1.36M | 1.52M | 1.26M | 1.02M | 643.90K | 434.94K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | -75.00K | 4.17M | 1.36M | 1.52M | 1.26M | 1.02M | 643.90K | 434.94K |
| Other Expenses | -5.70M | 5.13M | 2.11M | 1.60M | 850.08K | 687.30K | 202.12K | 38.14K |
| Operating Expenses | -5.70M | 5.13M | 3.47M | 3.12M | 2.11M | 1.71M | 846.02K | 473.08K |
| Cost & Expenses | -5.55M | 5.25M | 3.55M | 3.25M | 2.14M | 1.73M | 861.07K | 488.23K |
| Interest Income | 971.00K | 398.00K | 43.00K | 1.00K | 6.35K | 7.83K | 173.14 | -674.39 |
| Interest Expense | 62.00K | 60.00K | 43.00K | 134.00K | 10.05K | 7.22K | 25.75K | 15.63K |
| Depreciation & Amortization | 283.00K | 229.00K | 282.00K | 293.00K | 99.29K | 34.91K | 6.67K | 7.93K |
| EBITDA | -4.73M | -4.64M | -2.54M | -2.68M | -2.13M | -1.72M | -612.58K | -296.23K |
| EBITDA Ratio | -2,100.89% | -1,735.77% | -995.14% | -678.49% | -1,125.00% | -150,937.12% | -252.05% | -160.35% |
| Operating Income | -5.78M | -5.00M | -3.26M | -2.87M | -1.98M | -1.73M | -618.04K | -303.49K |
| Operating Income Ratio | -2,568.44% | -2,032.11% | -1,131.60% | -772.31% | -1,203.95% | -156,065.20% | -254.30% | -164.28% |
| Total Other Income/Expenses | 707.00K | 74.00K | 409.00K | -149.00K | -83.00K | -1.34K | -26.95K | -16.30K |
| Income Before Tax | -5.07M | -4.93M | -2.85M | -3.02M | -2.02M | -1.73M | -644.99K | -319.79K |
| Income Before Tax Ratio | -2,254.22% | -2,002.03% | -989.24% | -812.37% | -1,227.41% | -156,185.55% | -265.39% | -173.10% |
| Income Tax Expense | 0.00 | 281.00K | 10.00K | 135.00K | 228.53K | 5.88K | 502.00 | 137.81 |
| Net Income | -5.07M | -5.21M | -2.86M | -3.16M | -2.25M | -1.65M | -507.18K | -320.60K |
| Net Income Ratio | -2,254.22% | -2,116.26% | -992.71% | -848.66% | -1,366.43% | -148,935.44% | -208.69% | -173.54% |
| EPS | -0.79 | -0.83 | -0.50 | -0.59 | -0.51 | -0.50 | -0.15 | -0.10 |
| EPS Diluted | -0.79 | -0.81 | -0.50 | -0.59 | -0.51 | -0.50 | -0.15 | -0.10 |
| Weighted Avg Shares Out | 6.40M | 6.24M | 5.76M | 5.36M | 4.36M | 3.34M | 3.34M | 3.34M |
| Weighted Avg Shares Out (Dil) | 6.40M | 6.43M | 5.76M | 5.36M | 4.36M | 3.34M | 3.34M | 3.34M |
No news found for: ICE.WA
Source: https://incomestatements.info
Category: Stock Reports